Noblis’ BioVelocity Makes Top Four in the Northern Virginia Technology Council Destination Innovation Competition

As a finalist, BioVelocity moves on to compete for the honor of most innovative technology in the Health, Education, and Energy category

Destination Innovation, a program presented by the Northern Virginia Technology Council (NVTC) and The Washington Post's Capital Business, highlights technology advancements emerging from the Washington metropolitan area. Each year they hold a competition to find the companies with the most innovative technologies.

Last week, in the first round of the competition for the Health, Education, and Energy category, The Washington Post held an online poll where visitors could vote for their favorite out of eight companies. Noblis received enough online votes to move on as one of the top four category finalists, and will go to the next round of competition to exhibit and compete during the Destination Innovation event on April 29, 2015 at The Washington Post  headquarters. 

Read more about the competition.

About BioVelocity

BioVelocity is a Noblis-developed whole genome analysis platform that offers rapid detection of singular nucleotide polymorphism insertions or deletions and other genomic features 50 times faster than industry standard.

Learn more about BioVelocity.

Watch the BioVelocity video.

Noblis Expert

Sterling Thomas

As an informaticist, Sterling analyzes large, diverse data-sets to extrapolate valuable results for many clients.
Read more

Site Map

Home

Noblis, Inc. 2002 Edmund Halley Dr, Reston, VA 20191 703.610.2000 Terms of Use | Privacy Policy | Copyright 2012 Noblis, Inc. All rights reserved.